Chinese Firm Buys AMC Movie Theater Chain in Largest Sale Ever of U.S. Company to China
Tuesday, May 22, 2012
In another first for China, the Asian giant’s largest entertainment group has reached a deal to purchase the second biggest theater chain in the U.S., making the sale the largest to date of an American business to the Chinese.
The Dalian Wanda Group, controlled by billionaire real-estate developer Wang Jianlin, will pay $2.6 billion for AMC Entertainment Holdings Inc. Two billion of the $2.6 billion represents debt that Wanda will take on as part of the purchase from the previous owners, which included private-equity firms JPMorgan Partners, Apollo Global Management and Bain Capital.
The deal not only represents the largest purchase of an American company by China, but also establishes Wanda as the largest theater operator in the world.
And Wanda has plans to grow even larger, as it seeks to buy other American theater chains and European cinema operators as well.
Wang’s goal is to control at least 20% of the world theater market by 2020. A former officer in the Chinese army, Wang joined the Chinese Communist Party in 1996.
To Learn More:
China’s Wanda To Buy AMC Cinema Chain For $2.6 Billion (by Zachary Mider, Bloomberg)
Deal Expands Chinese Influence on Hollywood (by Michael Cieply, New York Times)
Why a Chinese Company Wants to Own Your Local Movie Theater (by Jordan Weissmann, The Atlantic)
Federal Reserve Allows First Chinese Government Takeover of U.S. Bank (by Noel Brinkerhoff, AllGov)
Wang Jianlin's Property Empire Built on Close Government Ties (Want China Times)
- Top Stories
- Unusual News
- Where is the Money Going?
- U.S. and the World
- Appointments and Resignations
- Latest News
- California Declares E-Cigarettes a Health Threat
- Justice Dept. to Tell Thousands of Immigrants they will have to Wait for Hearings until November 2019
- Groups Sue EPA over Failure to Regulate Stinking Pollution
- Director of the National Center for Environmental Assessment: Who Is Kenneth Olden?
- Insurance Companies Avoid Patients with HIV/AIDS by Overcharging for Medications